E-CBT DTx for Post Traumatic Headaches in Adults with History of TBI

Last updated: January 6, 2025
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Overall Status: Active - Recruiting

Phase

N/A

Condition

Migraine (Pediatric)

Chronic Pain

Headaches

Treatment

AMMO SHAM

AMMO PTH DTx

Clinical Study ID

NCT06669780
AMMO-TBI-2023
  • Ages 18-70
  • All Genders

Study Summary

The AMMO digital therapeutic (DTx) study will provide an online based program for participants with migraines after head injury to follow for 12 weeks. This study aims to see if using cognitive behavioral therapy aimed at military service members in an online self administered platform is effective therapy in the relief of migraines compared. The study will use a single blind online comparative program to test the effect.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Be aged ≥ 18 to ≤ 70 years

  • Have a history of concussive TBI ≥ 3 months prior to enrollment:

  • A concussive TBI is defined by having at least one of the following after a headtrauma (ACRM, 1993) oAny period of loss of consciousness; oAny loss of memory forevents immediately before or after the accident; oAny alteration in mental state atthe time of the accident (e.g., feeling dazed, disoriented, or confused); and oFocalneurological deficit(s) that may or may not be transient oThe injury must not exceedany of the following (ACRM, 1993):

  • Loss of consciousness of approximately 30 minutes or less;

  • After 30 minutes an initial GCS score of 13-15; and

  • PTA not greater than 24 hours

  • Head trauma resulting in concussive TBI can be due to blast or non-blastmechanisms

  • Head trauma resulting in concussive TBI can have occurred any time in theparticipant's life: prior to military service, during deployment, in garrison,or after leaving military service

  • Have a history of chronic PTH defined as: o Headache is reported to have developed (or worsened) after one of the following*:

  • The injury to the head;

  • Regaining of consciousness following the injury to the head; or

  • Discontinuation of medication(s) impairing ability to sense or report headachefollowing the injury to the head

  • Not better accounted for by another ICHD-3 diagnosis** o The headache persists for >3 months after its onset (ICHD, 2013)

  • Have a HIT-6™ score of ≥ 56 to 78 indicative of substantial impact (56-59) or severeimpact (60-78) on functioning (Yang, Rendas-Baum, Varon, & Kosinski, 2011)

  • Be able to provide written, informed consent in English and follow study-relatedinstructions

  • Have ownership of or reliable access to a smartphone with a data plan or internetconnecting capabilities

  • Be aged ≥ 18 to ≤ 70 years

  • Have a history of concussive TBI ≥ 3 months prior to enrollment:

  • A concussive TBI is defined by having at least one of the following after a headtrauma (ACRM, 1993):

  • Any period of loss of consciousness;

  • Any loss of memory for events immediately before or after the accident;

  • Any alteration in mental state at the time of the accident (e.g., feelingdazed, disoriented, or confused); and

  • Focal neurological deficit(s) that may or may not be transient

  • The injury must not exceed any of the following (ACRM, 1993):

  • Loss of consciousness of approximately 30 minutes or less;

  • After 30 minutes an initial GCS score of 13-15; and

  • PTA not greater than 24 hours

  • Head trauma resulting in concussive TBI can be due to blast or non-blastmechanisms

  • Head trauma resulting in concussive TBI can have occurred any time in theparticipant's life: prior to military service, during deployment, in garrison,or after leaving military service

  • Have a history of chronic PTH defined as: o Headache is reported to have developed (or worsened) after one of the following*:

  • The injury to the head;

  • Regaining of consciousness following the injury to the head; or

  • Discontinuation of medication(s) impairing ability to sense or report headachefollowing the injury to the head

  • Not better accounted for by another ICHD-3 diagnosis** o The headache persists for >3 months after its onset (ICHD, 2013)

  • Have a HIT-6™ score of ≥ 56 to 78 indicative of substantial impact (56-59) or severeimpact (60-78) on functioning (Yang, Rendas-Baum, Varon, & Kosinski, 2011)

  • Be able to provide written, informed consent in English and follow study-relatedinstructions

  • Have ownership of or reliable access to a smartphone with a data plan or internetconnecting capabilities

Exclusion

Exclusion Criteria:

  • They experienced a moderate or severe TBI

  • Their secondary headache is better accounted for by the ICHD-3 diagnosis of 8.2medication-overuse headache; must meet diagnostic criteria for at least 1medication-overuse headache diagnosis (8.2.1-8.2.8)

  • They are currently engaged in psychotherapeutic treatment or have engaged inpsychotherapeutic treatment within 8 weeks prior to trial enrollment (for moreinformation regarding recent treatment in potential participants, see section '3.2Study Procedures,' sub-section 'Baseline Evaluation')

  • They report change or discontinuation of headache prophylaxis in the past 4 weeks

  • They report active psychotic or bipolar symptoms

  • In the opinion of the investigator, they have other considerations that mayadversely affect patient safety, participation, or scientific validity of the databeing collected (including, but not limited to, active plan or intent for suicide,visual impairment, hand dysfunction or amputation, substantial cognitive impairment,life expectancy of less than 6 months)

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: AMMO SHAM
Phase:
Study Start date:
January 03, 2024
Estimated Completion Date:
June 30, 2026

Study Description

The AMMO digital therapeutic (DTx) will be a novel intervention for PTH following concussive TBI, therefore this project is a pilot trial designed to test this new treatment. This pilot is a single-blind, randomized, controlled, interventional trial of current and former military personnel along with civilians with a history of concussive TBI and current PTH. The pilot trial will be conducted via online portal accessible by smartphone, tablet, or computer with remote interaction between participants and study staff. The pilot trial will include up to 100 participants randomized to either the active intervention or a comparison condition at a 1:1 ratio, and will provide preliminary data to determine the sample size of a future full clinical trial. Participants will complete a 12 week intervention period followed by a follow-up assessment 4 weeks after intervention is complete. Participants randomized to the comparison group will be provided access to the open label after end of 16 week follow-up.

In addition, updates to the DTx to improve usability and acceptability will be made if necessary based on feedback from the pilot trial, then applied to the final DTx used in a future, larger, clinical trial.

Connect with a study center

  • 100% Remote Recruitment: Center for Neurscience and Regenerative Medicine

    Bethesda, Maryland 20817
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.